drugset / Trial / NCT03092245
Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial
Phase 2
Completed
44 enrolled
Rigshospitalet, Denmark
Octapharma · collabUniversity of Iceland · collab
RandomizedFactorialOpen-labelTreatment
Summary
Efficacy and safety of OctaplasLG® administration vs. crystalloids (standard) in patients with septic shock - a randomized, controlled, open-label investigator-initiated pilot trial
Timeline
- Start
- 2017-04-18
- Primary completion
- 2019-04-17
- Completion
- 2019-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Octaplas LG | Other / unclassified | — | Other |
| Comparator | Ringer acetate | Other / unclassified | — | Other |